Mark A. Wainberg, Ph.D.
Dr. Wainberg died unexpectedly on April 12, 2017, at the age of 71.
Among Dr. Wainberg's most notable achievements is his initial identification (in collaboration with BioChem Pharma) of the antiviral capabilities of 3TC in 1989. His laboratory continued to work on antiretroviral research, while Dr. Wainberg also turned his attention to investigating novel concepts in the development of an HIV vaccine and other modes of HIV prevention. He was a strong advocate of measures to enhance prevention of HIV infection in developing countries.
Dr. Wainberg was the chair of the XVI International AIDS Conference, which took place in Toronto, Canada, during the summer of 2006. He was a member of the Royal Society of Canada and an Officer of the Order of Canada.